Vitruvias Therapeutics Recalls Thyroid Medication Over Potency Concerns

Vitruvias Therapeutics has issued a nationwide recall for one lot of its Thyroid Tablets, USP 30 mg, due to potential superpotency. This poses serious health risks, especially for vulnerable populations like older adults, pregnant women, and infants, as precise thyroid hormone dosing is critical. Patients should consult a doctor before changing treatment.